Wilbanks Smith & Thomas Asset Management LLC Gilead Sciences, Inc. Transaction History

Wilbanks Smith & Thomas Asset Management LLC

$3.54 Billion
Q1 2024

10 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2022 May 05, 2022	SELL	$57.92 - $72.58 $269,501 - $337,714	-4,653 Closed	0 $0
Q2 2021 Aug 04, 2021	SELL	$63.47 - $69.35 $9,076 - $9,917	-143 Reduced 2.98%	4,653 $320,000
Q1 2021 May 11, 2021	BUY	$60.0 - $68.46 $287,760 - $328,334	4,796 New	4,796 $310,000
Q4 2018 Feb 08, 2019	SELL	$60.54 - $79.0 $169,572 - $221,279	-2,801 Closed	0 $0
Q3 2018 Nov 14, 2018	BUY	$71.28 - $78.92 $199,655 - $221,054	2,801 New	2,801 $217,000
Q2 2018 Aug 08, 2018	SELL	$64.88 - $75.68 $224,290 - $261,625	-3,457 Closed	0 $0
Q1 2018 May 15, 2018	BUY	$72.84 - $88.8 $251,807 - $306,981	3,457 New	3,457 $261,000
Q4 2017 Feb 07, 2018	SELL	$71.15 - $83.52 $248,953 - $292,236	-3,499 Closed	0 $0
Q3 2017 Nov 13, 2017	BUY	$72.11 - $85.47 $1,874 - $2,222	26 Added 0.75%	3,499 $283,000
Q2 2017 Aug 15, 2017	BUY	N/A	3,473	3,473 $246,000

Others Institutions Holding GILD

# of Institutions

1,927

Shares Held

994M

Call Options Held

10.5M

Put Options Held

9.75M

Black Rock Inc. New York, NY

121M
Shares

$11.1 Billion
0.19% of portfolio
Vanguard Group Inc Valley Forge, PA

115M
Shares

$10.7 Billion
0.18% of portfolio
Capital World Investors Los Angeles, CA

76.5M
Shares

$7.07 Billion
1.03% of portfolio
Capital Research Global Investors Los Angeles, CA

61.8M
Shares

$5.71 Billion
1.12% of portfolio
State Street Corp Boston, MA

60.2M
Shares

$5.56 Billion
0.21% of portfolio

View Full List

About GILEAD SCIENCES, INC.

Ticker GILD
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 1,253,369,984
Market Cap $116B
Description
Gilead Sciences, Inc., a biopharmaceutical company, discovers, develops, and commercializes medicines in the areas of unmet medical need in the United States, Europe, and internationally. The company provides Biktarvy, Genvoya, Descovy, Odefsey, Truvada, Complera/ Eviplera, Stribild, and Atripla products for the treatment of HIV/AIDS; Veklury, a...

More about GILD

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Wilbanks Smith & Thomas Asset Management LLC, based on Form 13F filings with the SEC.

News

Stay updated on Wilbanks Smith & Thomas Asset Management LLC with notifications on news.

Account